News Agency
Men's Weekly

Keymed Biosciences Announces 2023 Annual Results and Business Updates

  • Written by PR Newswire
  • Submitted a New Drug Application (NDA) of Stapokibart (CM310) for the treatment of moderate-to-severe AD in adults. The NDA was accepted by the China's NMPA and granted priority review.
  • Advanced a Phase III clinical study of Stapokibart for the treatment of CRSwNP in 2023. The results of the clinical trial are positive with co-primary endpoints...

Read more: Keymed Biosciences Announces 2023 Annual Results and Business Updates

How Pallet Racking Systems Improve Warehouse Organisation and Productivity

Warehouses and distribution centres play a vital role in modern supply chains. As businesses manage increasing inventory volumes and faster delivery expectations, efficient storage systems have become more important than ever. One of the most effective solutions used by warehouses... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion